Showing 17,961 - 17,980 results of 36,028 for search '(( 2 de decrease ) OR ( 50 ((((we decrease) OR (nn decrease))) OR (a decrease)) ))', query time: 1.20s Refine Results
  1. 17961

    DataSheet_1_Characteristics of humoral and cellular responses to coronavirus disease 2019 (COVID-19) inactivated vaccine in central China: A prospective, multicenter, longitudinal... by Youhua Yuan (773291)

    Published 2023
    “…The positive rate of neutralizing antibodies peaked at 97.7% at 60–90 days, decreased, and stabilized at 82.9% at 181–240 days post-vaccination. …”
  2. 17962

    Data_Sheet_1_Long-term phenobarbital treatment is effective in working-age patients with epilepsy in rural Northeast China: a 10-year follow-up study.docx by Rongxin Li (3552779)

    Published 2024
    “…During the first year of treatment, 75.2% of patients experienced a50% reduction in seizure frequency compared with baseline (considered as treatment effectiveness); 53.7% of patients were seizure-free. …”
  3. 17963
  4. 17964

    Data_Sheet_1_Immune-Phenotyping and Transcriptomic Profiling of Peripheral Blood Mononuclear Cells From Patients With Breast Cancer: Identification of a 3 Gene Signature Which Pred... by Gemma A. Foulds (315263)

    Published 2018
    “…Although chemotherapy had no effect on the percentage of Treg, MDSC and NK cells, the expression of inhibitory receptors CD85j, LIAR and NKG2A and activating receptors NKp30 and NKp44 on NK cells increased, concomitant with a decreased expression of NKp46 and DNAM-1 activating receptors. …”
  5. 17965

    Image_5_Immune-Phenotyping and Transcriptomic Profiling of Peripheral Blood Mononuclear Cells From Patients With Breast Cancer: Identification of a 3 Gene Signature Which Predicts... by Gemma A. Foulds (315263)

    Published 2018
    “…Although chemotherapy had no effect on the percentage of Treg, MDSC and NK cells, the expression of inhibitory receptors CD85j, LIAR and NKG2A and activating receptors NKp30 and NKp44 on NK cells increased, concomitant with a decreased expression of NKp46 and DNAM-1 activating receptors. …”
  6. 17966

    Table_1_Immune-Phenotyping and Transcriptomic Profiling of Peripheral Blood Mononuclear Cells From Patients With Breast Cancer: Identification of a 3 Gene Signature Which Predicts... by Gemma A. Foulds (315263)

    Published 2018
    “…Although chemotherapy had no effect on the percentage of Treg, MDSC and NK cells, the expression of inhibitory receptors CD85j, LIAR and NKG2A and activating receptors NKp30 and NKp44 on NK cells increased, concomitant with a decreased expression of NKp46 and DNAM-1 activating receptors. …”
  7. 17967

    Image_2_Immune-Phenotyping and Transcriptomic Profiling of Peripheral Blood Mononuclear Cells From Patients With Breast Cancer: Identification of a 3 Gene Signature Which Predicts... by Gemma A. Foulds (315263)

    Published 2018
    “…Although chemotherapy had no effect on the percentage of Treg, MDSC and NK cells, the expression of inhibitory receptors CD85j, LIAR and NKG2A and activating receptors NKp30 and NKp44 on NK cells increased, concomitant with a decreased expression of NKp46 and DNAM-1 activating receptors. …”
  8. 17968

    Table_2_Immune-Phenotyping and Transcriptomic Profiling of Peripheral Blood Mononuclear Cells From Patients With Breast Cancer: Identification of a 3 Gene Signature Which Predicts... by Gemma A. Foulds (315263)

    Published 2018
    “…Although chemotherapy had no effect on the percentage of Treg, MDSC and NK cells, the expression of inhibitory receptors CD85j, LIAR and NKG2A and activating receptors NKp30 and NKp44 on NK cells increased, concomitant with a decreased expression of NKp46 and DNAM-1 activating receptors. …”
  9. 17969

    Image_1_Immune-Phenotyping and Transcriptomic Profiling of Peripheral Blood Mononuclear Cells From Patients With Breast Cancer: Identification of a 3 Gene Signature Which Predicts... by Gemma A. Foulds (315263)

    Published 2018
    “…Although chemotherapy had no effect on the percentage of Treg, MDSC and NK cells, the expression of inhibitory receptors CD85j, LIAR and NKG2A and activating receptors NKp30 and NKp44 on NK cells increased, concomitant with a decreased expression of NKp46 and DNAM-1 activating receptors. …”
  10. 17970

    Table_3_Immune-Phenotyping and Transcriptomic Profiling of Peripheral Blood Mononuclear Cells From Patients With Breast Cancer: Identification of a 3 Gene Signature Which Predicts... by Gemma A. Foulds (315263)

    Published 2018
    “…Although chemotherapy had no effect on the percentage of Treg, MDSC and NK cells, the expression of inhibitory receptors CD85j, LIAR and NKG2A and activating receptors NKp30 and NKp44 on NK cells increased, concomitant with a decreased expression of NKp46 and DNAM-1 activating receptors. …”
  11. 17971

    Table_4_Immune-Phenotyping and Transcriptomic Profiling of Peripheral Blood Mononuclear Cells From Patients With Breast Cancer: Identification of a 3 Gene Signature Which Predicts... by Gemma A. Foulds (315263)

    Published 2018
    “…Although chemotherapy had no effect on the percentage of Treg, MDSC and NK cells, the expression of inhibitory receptors CD85j, LIAR and NKG2A and activating receptors NKp30 and NKp44 on NK cells increased, concomitant with a decreased expression of NKp46 and DNAM-1 activating receptors. …”
  12. 17972

    Specific knock-down of HIF-1α in MSPCs but not in ECFCs inhibits vessel formation <i>in vivo</i>. by Nicole A. Hofmann (138477)

    Published 2012
    “…A significantly decreased capacity to form perfused vessels was found in implants containing shHIF-1α transfected MSPCs compared to untreated co-transplants. …”
  13. 17973

    Human vessel formation after progenitor co-transplantation depends on hypoxia-induced factors in MSPCs but not ECFCs. by Nicole A. Hofmann (138477)

    Published 2012
    “…Human mesodermal origin was visualized with anti-human vimentin monoclonal antibody staining (h.Vimentin, brown; mouse and human nuclei counterstained with hematoxylin, blue; third row; scale bar 50 µm). Plugs contain different numbers of h.Vimentin-negative infiltrating mouse CD45<sup>+</sup> hematopoietic cells (see <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0044468#pone.0044468.s006" target="_blank">Figure S6C</a>). …”
  14. 17974

    <i>NOTCH3</i> Variants and Risk of Ischemic Stroke by Owen A. Ross (139522)

    Published 2013
    “…</p> <p>Results</p><p>Sequencing of the 269 SWISS probands identified one (0.4%) with small vessel type stroke carrying a known CADASIL mutation (p.R558C; Exon 11). Of the 19 common <i>NOTCH3</i> variants identified, the only variant significantly associated with ischemic stroke after multiple testing adjustment was p.R1560P (rs78501403; Exon 25) in the combined SWISS and ISGS Caucasian series (Odds Ratio [OR] 0.50, P=0.0022) where presence of the minor allele was protective against ischemic stroke. …”
  15. 17975

    Time-limited downregulation of cerebellar neurophysiological processes in NHPs during LACV infection. by Olga A. Maximova (3115716)

    Published 2025
    “…Note: (i) pial lymphocytic infiltration (yellow arrows) appeared at 7 dpi (<b>G</b>), increased at 14 dpi (<b>H</b>), and decreased at 21 dpi (returning to the level seen at 7 dpi) (<b>I</b>); (ii) a rare focal lesion (red asterisk in H) with depleted MAP2-IR in the Purkinje cell layer (PCL), granule cell layer (GrCL) neurons, and partially in the molecular layer (ML) is spatially associated with the increased pial lymphocytic infiltration. …”
  16. 17976

    Coordinated polarity induced by high flow triggers vessel regression. by Claudio A. Franco (124909)

    Published 2015
    “…Scale bars (<b>A</b>: 50 μm; <b>E</b>: 20 μm). The data used to make this figure can be found in <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.1002125#pbio.1002125.s001" target="_blank">S1 Data</a>.…”
  17. 17977

    Simplified depiction of hyperthermia impacts on the intrafollicular complement and coagulation cascade. by Louisa A. Rispoli (8201232)

    Published 2019
    “…Alpha-2-Macroglobulin (A2M) is an anti-proteinase that complexes with proteinases such as kallikrein [<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0227095#pone.0227095.ref050" target="_blank">50</a>] to inhibit proteolytic activity.…”
  18. 17978

    DataSheet1_Conservation status and historical relatedness of South African communal indigenous goat populations using a genome-wide single-nucleotide polymorphism marker.docx by T. C. Chokoe (13217025)

    Published 2022
    “…The use of Illumina goat SNP50K BeadChip shows that there was a migration route of communal indigenous goat populations from the northern part (LP) of South Africa to the eastern areas of the KZN that confirmed their historical relatedness and coincides with the migration periods of the Bantu nation.…”
  19. 17979

    In Patients with Established RA, Positive Effects of a Randomised Three Month WBV Therapy Intervention on Functional Ability, Bone Mineral Density and Fatigue Are Sustained for up... by Alessandra Prioreschi (2609719)

    Published 2016
    “…Hip BMD was significantly reduced in the CON group (0.97(0.05) to 0.84(0.05) g.cm<sup>-2</sup>, p = 0.01), while no decreases were seen in the WBV group (1.01(0.05) to 0.94(0.05) g.cm<sup>-2</sup>, p = 0.50). …”
  20. 17980

    Image_1_JK5G postbiotics attenuate immune-related adverse events in NSCLC patients by regulating gut microbiota: a randomized controlled trial in China.tif by Mengting Chen (1419172)

    Published 2023
    “…Moreover, the JK5G group had a lower incidence of anemia (63.33% vs. 13.33%, p < 0.001), decreased lymphocyte count (20.00% vs. 0%, p = 0.010), decreased appetite (53.33% vs. 16.67%, p = 0.003), nausea (33.33% vs. 6.67%, p = 0.010), and asthenia (30.00% vs. 6.67%, p = 0.017) than the control group. …”